Inventor · disambiguated record
Juan Fernando Vera Valdes
Also filed as: VERA VALDES JUAN F · VERA VALDES JUAN FERNANDO
7 granted patents·11 pending applications·8 citations·filing 2014–2024
77Inventor score
Files withBAYLOR COLLEGE MEDICINE18
Top patents by PatentIndex Score
18 records- 0191US10385316B2Generation of CTL lines with specificity against multiple tumor antigens or multiple virusesBAYLOR COLLEGE MEDICINE·Filed 2016·Granted Aug 20, 2019·8 cites·15 claims
- 0285US2023357721A1Generation of ctl lines with specificity against multiple tumor antigens or multiple virusesBAYLOR COLLEGE MEDICINE·Filed 2023·Application pending·0 cites
- 0383US2023114971A1Generation of ctl lines with specificity against multiple tumor antigens or multiple virusesBAYLOR COLLEGE MEDICINE·Filed 2022·Application pending·0 cites
- 0482US12435309B2Generation of CTL lines with specificity against multiple tumor antigens or multiple virusesBAYLOR COLLEGE MEDICINE·Filed 2022·Granted Oct 7, 2025·0 cites·8 claims
- 0580US11981923B2Pepmixes to generate multiviral CTLS with broad specificityBAYLOR COLLEGE MEDICINE·Filed 2022·Granted May 14, 2024·0 cites·11 claims
- 0677US12227764B2Pepmixes to generate multiviral CTLs with broad specificityBAYLOR COLLEGE MEDICINE·Filed 2021·Granted Feb 18, 2025·0 cites·21 claims
- 0777US2025009870A1Immunogenic antigen identification from a pathogen and correlation to clinical efficacyBAYLOR COLLEGE MEDICINE·Filed 2024·Application pending·0 cites
- 0871US11931408B2Immunogenic antigen identification from a pathogen and correlation to clinical efficacyBAYLOR COLLEGE MEDICINE·Filed 2021·Granted Mar 19, 2024·0 cites·6 claims
- 0963US11547740B2Histone deacetylase (HDAC) inhibitor up-regulates car expression and targeted antigen intensity, increasing antitumor efficacyBAYLOR COLLEGE MEDICINE·Filed 2019·Granted Jan 10, 2023·0 cites·11 claims
- 1060US2024335537A1Engineered soluble decoy receptors to enhance cancer immunotherapyBAYLOR COLLEGE MEDICINE·Filed 2022·Application pending·0 cites
- 1158US2020140520A1Immunosuppressive tgf-b signal converterBAYLOR COLLEGE MEDICINE·Filed 2020·Application pending·0 cites
- 1255US2023210901A1Overcoming the tumor microenvironment for cell therapy by targeting myeloid derived suppressor cells through a trail-r2 specific receptorBAYLOR COLLEGE MEDICINE·Filed 2021·Application pending·0 cites
- 1353US10279009B2Histone deacetylase (HDAC) inhibitor up-regulates car expression and targeted antigen intensity, increasing antitumor efficacyBAYLOR COLLEGE MEDICINE·Filed 2014·Granted May 7, 2019·0 cites·15 claims
- 1453US2023295565A1Universal antigen-specific t cell banks and methods of making and using the same therapeuticallyBAYLOR COLLEGE MEDICINE·Filed 2021·Application pending·0 cites
- 1552US2023028788A1T cell performance assay as a prognostic factor for clinical outcomeBAYLOR COLLEGE MEDICINE·Filed 2020·Application pending·0 cites
- 1650US2022169986A1Multi-respiratory virus antigen-specific t cells and methods of making and using the same therapeuticallyBAYLOR COLLEGE MEDICINE·Filed 2020·Application pending·0 cites
- 1746US2022257654A1Antigen-specific t cell banks and methods of making and using the same therapeuticallyBAYLOR COLLEGE MEDICINE·Filed 2020·Application pending·0 cites
- 1829US2017246278A1Bipartite and tripartite signaling immune cellsBAYLOR COLLEGE MEDICINE·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Juan Fernando Vera Valdes files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →